QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
NASDAQ:MDWD

MediWound - MDWD Stock Forecast, Price & News

$13.73
-0.44 (-3.11%)
(As of 01/30/2023 04:32 PM ET)
Add
Compare
Today's Range
$13.71
$14.13
50-Day Range
$8.47
$77.28
52-Week Range
$8.05
$17.75
Volume
23,333 shs
Average Volume
56,570 shs
Market Capitalization
$79.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.40

MediWound MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
194.2% Upside
$40.40 Price Target
Short Interest
Healthy
0.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.97mentions of MediWound in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.56) to ($1.61) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

477th out of 1,049 stocks

Medicinals & Botanicals Industry

5th out of 15 stocks


MDWD stock logo

About MediWound (NASDAQ:MDWD) Stock

MediWound Ltd. is a biopharmaceutical company, which engages in the development, manufacture, and commercialization of products to address needs in the fields of severe burns, chronic wounds, and other hard-to-heal wounds. Its product is NexoBrid. The company was founded by Lior Rosenberg and Marian Gorecki in January 2000 and is headquartered in Yavne, Israel.

Receive MDWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediWound and its competitors with MarketBeat's FREE daily newsletter.

MDWD Stock News Headlines

Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
FDA Approves MediWound's NexoBrid For Burn Treatment
MediWound Strengthens European Presence of NexoBrid®
Is This The End of Capitalism?
EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…
MediWound Announces a 1-for-7 Reverse Share Split
MediWound to Report Third Quarter 2022 Financial Results
MediWound Announces Formation of Strategic Advisory Board
See More Headlines
Receive MDWD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediWound and its competitors with MarketBeat's FREE daily newsletter.

MDWD Company Calendar

Last Earnings
11/15/2022
Today
1/30/2023
Next Earnings (Estimated)
3/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MDWD
Employees
77
Year Founded
2001

Price Target and Rating

Average Stock Price Forecast
$40.40
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$23.00
Forecasted Upside/Downside
+194.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
6 Analysts

Profitability

Net Income
$-13,550,000.00
Pretax Margin
-79.97%

Debt

Sales & Book Value

Annual Sales
$23.76 million
Book Value
($1.18) per share

Miscellaneous

Free Float
5,285,000
Market Cap
$79.91 million
Optionable
Not Optionable
Beta
0.99

Social Links


Key Executives

  • Ofer Gonen
    Chief Executive Officer & Director
  • Tzvi Palash
    Chief Operating Officer
  • Boaz Gur-Lavie
    Chief Financial Officer
  • Ety Klinger
    Chief Research & Development Officer
  • Robert J. Snyder
    Chief Medical Officer













MDWD Stock - Frequently Asked Questions

Should I buy or sell MediWound stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediWound in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MDWD shares.
View MDWD analyst ratings
or view top-rated stocks.

What is MediWound's stock price forecast for 2023?

6 brokerages have issued 12 month target prices for MediWound's shares. Their MDWD share price forecasts range from $23.00 to $56.00. On average, they predict the company's share price to reach $40.40 in the next year. This suggests a possible upside of 188.2% from the stock's current price.
View analysts price targets for MDWD
or view top-rated stocks among Wall Street analysts.

How have MDWD shares performed in 2023?

MediWound's stock was trading at $13.49 on January 1st, 2023. Since then, MDWD stock has increased by 3.9% and is now trading at $14.02.
View the best growth stocks for 2023 here
.

Are investors shorting MediWound?

MediWound saw a decrease in short interest during the month of January. As of January 15th, there was short interest totaling 17,900 shares, a decrease of 59.0% from the December 31st total of 43,700 shares. Based on an average daily volume of 58,000 shares, the short-interest ratio is presently 0.3 days. Currently, 0.6% of the shares of the stock are sold short.
View MediWound's Short Interest
.

When is MediWound's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 16th 2023.
View our MDWD earnings forecast
.

How were MediWound's earnings last quarter?

MediWound Ltd. (NASDAQ:MDWD) released its quarterly earnings data on Tuesday, November, 15th. The biopharmaceutical company reported ($0.91) earnings per share for the quarter, missing the consensus estimate of ($0.70) by $0.21. The biopharmaceutical company earned $5.80 million during the quarter, compared to analysts' expectations of $4.65 million.

When did MediWound's stock split?

Shares of MediWound reverse split on the morning of Tuesday, December 20th 2022. The 1-7 reverse split was announced on Tuesday, December 20th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, December 20th 2022. An investor that had 100 shares of stock prior to the reverse split would have 14 shares after the split.

What other stocks do shareholders of MediWound own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediWound investors own include OPKO Health (OPK), Sorrento Therapeutics (SRNE), Blackstone (BX), Dynavax Technologies (DVAX), Geron (GERN), Idera Pharmaceuticals (IDRA), Mastercard (MA), SCYNEXIS (SCYX), Vascular Biogenics (VBLT) and Wells Fargo & Company (WFC).

What is MediWound's stock symbol?

MediWound trades on the NASDAQ under the ticker symbol "MDWD."

Who are MediWound's major shareholders?

MediWound's stock is owned by a number of retail and institutional investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of MediWound?

Shares of MDWD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MediWound's stock price today?

One share of MDWD stock can currently be purchased for approximately $14.02.

How much money does MediWound make?

MediWound (NASDAQ:MDWD) has a market capitalization of $81.60 million and generates $23.76 million in revenue each year. The biopharmaceutical company earns $-13,550,000.00 in net income (profit) each year or ($3.7089) on an earnings per share basis.

How can I contact MediWound?

MediWound's mailing address is 42 HAYARKON STREET, YAVNE L3, 8122745. The official website for the company is www.mediwound.com. The biopharmaceutical company can be reached via phone at 972779714100, via email at afields@lhai.com, or via fax at 972-77-971-4111.

This page (NASDAQ:MDWD) was last updated on 1/30/2023 by MarketBeat.com Staff